[Retracted] Using Haemocoagulase Agkistrodon in Patients Undergoing Transurethral Plasmakinetic Resection of the Prostate: A Pilot, Real-World, and Propensity Score-Matched Study

Table 5

Effects of haemocoagulase agkistrodon for injection, hemocoagulase for injection, or hemocoagulase bothrops atrox for injection on patients after transurethral bipolar plasmakinetic prostatectomy.

Outcomes	Haemocoagulase agkistrodon ()	Hemocoagulase ()		Haemocoagulase agkistrodon ()	Hemocoagulase Bothrops Atrox ()
Hospitalization time (days)	7.00 (5.00, 8.00)	9.00 (8.00, 10.00)	<0.001	7.00 (6.00, 8.00)	8.00 (7.00, 10.00)	<0.001
Bladder irrigation time (hours)	41.00 (21.00, 64.00)	45.00 (23.00, 71.00)	0.06	45.00 (27.00, 71.00)	49.00 (45.00, 72.00)	0.04
Catheterization time (hours)	109.00 (88.00, 129.00)	164.00 (114.00, 189.00)	<0.001	114.00 (88.00, 143.00)	141.00 (120.00, 166.00)	<0.001
Urination unobstructed			0.68			0.36
Yes	63 (96.92%)	61 (93.85%)		70 (98.59%)	67 (94.37%)
No	2 (3.08%)	4 (6.15%)
Blood transfusion			1			1
Yes	1 (1.54%)	2 (3.08%)		1 (1.41%)	0 (0.00%)
No	64 (98.46%)	63 (96.92%)		70 (98.59%)	75 (100%)